The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial.
We report on the effect of hemoadsorption therapy to reduce cytokines in septic patients with respiratory failure.This was a randomized, controlled, open-label, multicenter trial. Mechanically ventilated patients with severe sepsis or septic shock and acute lung injury or acute respiratory distress...
Main Authors: | Dirk Schädler, Christine Pausch, Daniel Heise, Andreas Meier-Hellmann, Jörg Brederlau, Norbert Weiler, Gernot Marx, Christian Putensen, Claudia Spies, Achim Jörres, Michael Quintel, Christoph Engel, John A Kellum, Martin K Kuhlmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5662220?pdf=render |
Similar Items
-
Hemoadsorption by CytoSorb in septic patients: a case series
by: Klaus Kogelmann, et al.
Published: (2017-03-01) -
Hemoadsorption corrects hyperresistinemia and restores anti-bacterial neutrophil function
by: Anthony Bonavia, et al.
Published: (2017-08-01) -
Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19
by: Paul Biever, et al.
Published: (2021-04-01) -
Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)
by: Masoumeh Asgharpour, et al.
Published: (2020-08-01) -
Case Series: Efficacy and Safety of Hemoadsorption With HA-330 Adsorber in Septic Pediatric Patients With Cancer
by: Vitaliy Sazonov, et al.
Published: (2021-06-01)